IDEAYA Reports Second Quarter 2025 Financial Results and Provides Business Update: https://lnkd.in/gSzziNNW
IDEAYA Biosciences
Biotechnology Research
South San Francisco, California 17,446 followers
Synthetic lethality precision medicine oncology company pursuing– an emerging class of precision medicine targets.
About us
IDEAYA is an oncology-focused precision medicine company. Our teams are committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. We are advancing therapeutics that have the potential to be first-in-class and/or best-in-class, with a primary focus in synthetic lethality – an emerging class of precision medicine targets. IDEAYA is headquartered in South San Francisco, California.
- Website
-
https://www.ideayabio.com
External link for IDEAYA Biosciences
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- South San Francisco, California
- Type
- Public Company
- Founded
- 2015
- Specialties
- Synthetic Lethality and Precision Medicine
Locations
-
Primary
Get directions
7000 Shoreline Court
350
South San Francisco, California 94080, US
Employees at IDEAYA Biosciences
Updates
-
IDEAYA Announces Proffered Paper Oral Presentation at ESMO 2025 for Phase 2 Clinical Trial of Neoadjuvant Darovasertib in Primary Uveal Melanoma: https://lnkd.in/ggZVAWc6
-
IDEAYA Announces 10-Year Anniversary R&D Day on September 8, 2025 to Present Multiple Clinical Data Updates and Outline Future Growth Strategy: https://lnkd.in/gE_wPVFN
-
-
IDEAYA and Hengrui Pharmaceuticals Announce Oral Presentation at IASLC 2025 World Conference on Lung Cancer for IDE849 (SHR-4849), a Potential First-in-Class DLL3-TOP1 ADC: https://lnkd.in/djxjhqw6
-
IDEAYA to Participate in Upcoming July 2025 Investor Relations Event: https://lnkd.in/gnKksguj
-
IDEAYA is hiring a Senior Director, Medical Science Liaisons, based in our South San Francisco Headquarters. This is a unique opportunity to build and lead the U.S. team of MSL's. We invite you to explore the job posting on our careers page: https://lnkd.in/gkYGBKb or apply directly here: https://lnkd.in/gXPWT8ah
-
-
We are hiring at IDEAYA Biosciences for a Senior Medical Director, Patient Safety and Pharmacovigilance. If you are looking for your next opportunity and are inspired by impacting patients lives, look no further! We invite you to explore the job posting on our careers page: https://lnkd.in/ggG7ndGe
-
-
IDEAYA to Participate in Upcoming June 2025 Investor Relations Events: https://lnkd.in/gAghvBpq
-
IDEAYA Reports First Quarter 2025 Financial Results and Provides Business Update: https://lnkd.in/gv8_RBTh
-
IDEAYA Announces US FDA IND-Clearance for IDE849, a Potential First-in-Class DLL3 TOP1 ADC, for a Phase 1 Study in Solid Tumors: https://lnkd.in/gq9JmmuU
-